Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Novelty Nobility.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Novelty Nobility
korearepublicofnew Flag
Country
Country
South Korea
Address
Address
6F, 227, Unjung-ro, Seongnam-si, Gyeonggi-do, S. Korea 13477
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

VB517 is a fully human mAb with low-picomolar affinity for c-KIT and has demonstrated potent suppression of human mast cell activation in preclinical models. ValenzaBio plans to initiate clinical studies of VB517 in 2023.


Lead Product(s): VB517

Therapeutic Area: Dermatology Product Name: VB517

Highest Development Status: IND EnablingProduct Type: Large molecule

Partner/Sponsor/Collaborator: ValenzaBio

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement February 15, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY